Assessment Of Implementing The Compass Trial Results In Routine Clinical Practice In Ontario, Canada: Insights From The Cardiovascular Health In Ambulatory Care Research Team (Canheart) Study
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2020)
摘要
The Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial showed decrease in major adverse cardiovascular events (MACE) with low-dose rivaroxaban (riva) and ASA vs ASA alone in patients (pts) with a history of CAD and/or PAD. The aim of this study was to examine a) the
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要